Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.

Jeroen A.C.M. Goos,Annemieke C. Hiemstra,Veerle M.H. Coupé,Begoňa Diosdado,W. Kooijman,P M Delis-Van Diemen,Cemile Karga,Jeroen A.M. Beliën,C. W. Menke-van der Houven van Oordt,Albert A. Geldof,Gerrit A. Meijer,Otto S. Hoekstra,Remond J. A. Fijneman

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.

2014

Jeroen A.C.M. Goos
Annemieke C. Hiemstra
Veerle M.H. Coupé
Begoňa Diosdado
W. Kooijman
P M Delis-Van Diemen
Cemile Karga
Jeroen A.M. Beliën
C. W. Menke-van der Houven van Oordt
Albert A. Geldof
Gerrit A. Meijer
Otto S. Hoekstra
Remond J. A. Fijneman

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases

Keywords:

Immunology
ATP synthase
Epidermal growth factor receptor
Prostaglandin-endoperoxide synthase 2
Colorectal cancer
Young adult
Pathology
Biomarker (medicine)
Medicine
prognostic biomarker

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations